Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
about
Bacterial Expression of Human Butyrylcholinesterase as a Tool for Nerve Agent Bioscavengers Development.Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.Proline-Based Carbamates as Cholinesterase Inhibitors.Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.Rapid Mechanistic Evaluation and Parameter Estimation of Putative Inhibitors in a Single-Step Progress-Curve Analysis: The Case of Horse Butyrylcholinesterase.Regulation of striatal cells and goal-directed behavior by cerebellar outputs
P2860
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
@en
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
@nl
type
label
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
@en
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
@nl
prefLabel
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
@en
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
@nl
P2093
P2860
P50
P356
P1433
P1476
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
@en
P2093
Adrian Podkowa
Anja Pišlar
Barbara Malawska
Boris Brus
Damijan Knez
Florian Nachon
Irena Mlinarič Raščan
Jacques-Philippe Colletier
Jasna Šlenc
P2860
P2888
P356
10.1038/SREP39495
P407
P577
2016-12-21T00:00:00Z